BlackRock
TEVA icon

BlackRock’s Teva Pharmaceuticals TEVA Stock Holding History

BlackRock’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16B Sell
63,894,301
-1,242,163
-2% -$41.4M 0.03% 423
2026
Q1 		$1.96B Buy
65,136,464
+6,833,776
+12% +$220M 0.03% 423
2025
Q4 		$1.82B Buy
58,302,688
+500,280
+0.9% +$12.3M 0.03% 441
2025
Q3 		$1.17B Buy
57,802,408
+3,484,026
+6% +$61.2M 0.02% 612
2025
Q2 		$910M Buy
54,318,382
+2,094,489
+4% +$33.8M 0.02% 689
2025
Q1 		$803M Buy
52,223,893
+1,640,067
+3% +$29.3M 0.02% 731
2024
Q4 		$1.11B Buy
50,583,826
+6,783,663
+15% +$123M 0.02% 581
2024
Q3 		$789M Buy
43,800,163
+812,381
+2% +$14.2M 0.02% 767
2024
Q2 		$699M Sell
42,987,782
-716,619
-2% -$11M 0.02% 792
2024
Q1 		$617M Buy
43,704,401
+2,039,540
+5% +$25.7M 0.01% 885
2023
Q4 		$435M Buy
41,664,861
+881,566
+2% +$8.23M 0.01% 1116
2023
Q3 		$416M Buy
40,783,295
+493,488
+1% +$4.6M 0.01% 1029
2023
Q2 		$303M Buy
40,289,807
+123,426
+0.3% +$1M 0.01% 1280
2023
Q1 		$355M Sell
40,166,381
-190,344
-0.5% -$1.88M 0.01% 1149
2022
Q4 		$368M Sell
40,356,725
-1,310,529
-3% -$11.4M 0.01% 1092
2022
Q3 		$336M Sell
41,667,254
-1,410,349
-3% -$12.5M 0.01% 1092
2022
Q2 		$324M Buy
43,077,603
+1,428,887
+3% +$12.4M 0.01% 1171
2022
Q1 		$391M Buy
41,648,716
+1,494,814
+4% +$12.5M 0.01% 1159
2021
Q4 		$322M Sell
40,153,902
-387,943
-1% -$3.5M 0.01% 1373
2021
Q3 		$395M Buy
40,541,845
+785,802
+2% +$7.36M 0.01% 1178
2021
Q2 		$394M Sell
39,756,043
-2,228,410
-5% -$23.6M 0.01% 1231
2021
Q1 		$485M Buy
41,984,453
+4,748,989
+13% +$54.5M 0.01% 1036
2020
Q4 		$359M Sell
37,235,464
-772,165
-2% -$7.4M 0.01% 1147
2020
Q3 		$342M Buy
38,007,629
+388,509
+1% +$4.11M 0.01% 981
2020
Q2 		$464M Sell
37,619,120
-117,187
-0.3% -$1.33M 0.02% 766
2020
Q1 		$339M Buy
37,736,307
+1,671,984
+5% +$17.1M 0.02% 814
2019
Q4 		$353M Buy
36,064,323
+526,979
+1% +$4.7M 0.01% 1069
2019
Q3 		$244M Buy
35,537,344
+578,947
+2% +$4.44M 0.01% 1258
2019
Q2 		$323M Buy
34,958,397
+1,175,800
+3% +$14.2M 0.01% 1076
2019
Q1 		$530M Buy
33,782,597
+42,498
+0.1% +$749K 0.02% 694
2018
Q4 		$520M Buy
33,740,099
+658,864
+2% +$13.5M 0.03% 632
2018
Q3 		$713M Buy
33,081,235
+1,122,592
+4% +$26.1M 0.03% 560
2018
Q2 		$777M Buy
31,958,643
+3,043,358
+11% +$62.1M 0.04% 502
2018
Q1 		$494M Sell
28,915,285
-905,961
-3% -$17.7M 0.02% 713
2017
Q4 		$565M Buy
29,821,246
+611,815
+2% +$9.2M 0.03% 644
2017
Q3 		$514M Buy
29,209,431
+1,719,511
+6% +$38.7M 0.03% 646
2017
Q2 		$913M Sell
27,489,920
-299,228
-1% -$9.26M 0.05% 391
2017
Q1 		$892M Buy
27,789,148
+26,296,961
+1,762% +$897M 0.05% 391
2016
Q4 		$54.1M Buy
1,492,187
+988,954
+197% +$39.5M 0.08% 295
2016
Q3 		$23.2M Sell
503,233
-67,972
-12% -$3.55M 0.03% 512
2016
Q2 		$28.7M Sell
571,205
-77,799
-12% -$4.14M 0.04% 438
2016
Q1 		$34.7M Buy
649,004
+14,609
+2% +$857K 0.06% 369
2015
Q4 		$41.6M Sell
634,395
-114,685
-15% -$7.09M 0.06% 346
2015
Q3 		$42.3M Sell
749,080
-107,153
-13% -$6.95M 0.07% 316
2015
Q2 		$50.6M Buy
856,233
+49,312
+6% +$3.04M 0.08% 287
2015
Q1 		$50.3M Buy
806,921
+244,983
+44% +$14.2M 0.07% 305
2014
Q4 		$32.3M Buy
561,938
+51,242
+10% +$2.85M 0.05% 408
2014
Q3 		$27.4M Buy
510,696
+330,955
+184% +$17.5M 0.04% 431
2014
Q2 		$9.42M Buy
179,741
+1,813
+1% +$92.7K 0.01% 695
2014
Q1 		$9.4M Buy
+177,928
New +$8.22M 0.02% 688

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock's TEVA Position: Q2 2026 in Review

BlackRock reduced its Teva Pharmaceuticals (TEVA) stake by 1.9% in Q2 2026, selling an estimated $41.4M and leaving 63,894,301 shares worth $2.16B. The position accounts for 0.03% of the portfolio, ranked #423.

BlackRock first reported a position in TEVA in Q1 2014 and has held it in 50 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • BlackRock held 63,894,301 shares of Teva Pharmaceuticals worth $2.16B as of Q2 2026.
  • BlackRock sold 1,242,163 Teva Pharmaceuticals shares in Q2 2026, an estimated $41.4M.
  • Teva Pharmaceuticals made up 0.03% of BlackRock's portfolio in Q2 2026, its #423 holding.
  • BlackRock first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 50 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.